Actionable insights straight to your inbox

logo_equities.svg

Opiant Pharmaceuticals Licenses Cannabinoid Overdose Therapy from Sanofi

Opiant is the developer of Narcan for opioid overdoses
  • 4 MIN READ
logo_equities_white

Sign up For our Newsletter

SITEMAP

Contact

© 2022 Equities News | Equities.com, Inc.